Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
Sponsor: Rep. Hoyle, Val T. (D-OR)15 cosponsorsIntroduced Aug 13, 2026
✆
In plain English
H.R. 10094 establishes a process requiring the federal government to negotiate prices for prescription drugs that were developed using taxpayer funding, with the goal of ensuring Americans pay reasonable prices for those medications. The bill creates a framework for "reasonable price agreements" between the government and drug manufacturers for drugs that received federal research support. Introduced by Rep. Val Hoyle (D-OR), the bill has 14 Democratic cosponsors and is currently in the House Committee on Energy and Commerce.
One email when they vote against their own party. Nothing else.
Nonpartisan · Unsubscribe in one click · We never sell your address
Track this bill
Get an alert when it moves to the next stage or gets a vote.
Share
Embed this tracker on your site
Paste this HTML into your blog post or website to show a live tracker for this bill.
The embedded card updates automatically as the bill progresses. Preview →
See something wrong on this page? Tell us what looks incorrect and what it should be — we’ll investigate and correct it.
Report incorrect information
Every figure on this site is supposed to trace back to an official source. If something
here is wrong, telling me is the fastest way it gets fixed — and corrections are
published.